Kirjallisuus
Käypähoitosuositus -linkit
Duodecim- ja Suomen Hammaslääkäriseura Apollonia -järjestöjen laatimat hammas- ja suulääketieteelliset Käypä Hoito -suositukset löytyvät seuraavan linkin alta:
Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines. Ariyawardana A, Cheng KKF, Kandwal A, Tilly V, Al-Azri AR, Galiti D, Chiang K, Vaddi A, Ranna V, Nicolatou-Galitis O, Lalla RV, Bossi P, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). Support Care Cancer. 2019 Oct;27(10):3985-3995. doi: 10.1007/s00520-019-04888-w. Epub 2019 Jul 8. PMID: 31286230
Diclofenac Mouthwash as a potential therapy for reducing pain and discomfort in chemo-radiotherapy-induced oral mucositis. Brennan PA, Lewthwaite R, Sakthithasan P, McGuigan S, Donnelly O, Alam P, Gomez RS, Fedele S. J Oral Pathol Med. 2020 Oct;49(9):956-959. doi: 10.1111/jop.13001. Epub 2020 Mar 10. PMID: 32017243
Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. Correa MEP, Cheng KKF, Chiang K, Kandwal A, Loprinzi CL, Mori T, Potting C, Rouleau T, Toro JJ, Ranna V, Vaddi A, Peterson DE, Bossi P, Lalla RV, Elad S. Support Care Cancer. 2020 May;28(5):2449-2456. doi: 10.1007/s00520-019-05217-x. Epub 2019 Dec 14. PMID: 31836937
Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT. Daikeler T, Mauramo M, Rovó A, Stern M, Halter J, Buser A, Tyndall A, Häusermann P, Gratwohl A, Tichelli A, Brennan MT, Waltimo T. Bone Marrow Transplant. 2013 Jul;48(7):988-93. doi: 10.1038/bmt.2012.260. Epub 2013 Jan 7. PMID: 23292241
Oral health risks associated with HLA-types of patients undergoing hematopoietic stem cell transplantation. Dobr T, Passweg J, Weber C, Tichelli A, Heim D, Meyer J, Gratwohl A, Waltimo T. Eur J Haematol. 2007 Jun;78(6):495-9. doi: 10.1111/j.1600-0609.2007.
The MASCC/ISOO mucositis guidelines 2019: the second set of articles and future directions. Elad S. Support Care Cancer. 2020 May;28(5):2445-2447. doi: 10.1007/s00520-019-05153-w. PMID: 32052136
The MASCC/ISOO Mucositis Guidelines 2019 Update: introduction to the first set of articles. Elad S. Support Care Cancer. 2019 Oct;27(10):3929-3931. doi: 10.1007/s00520-019-04895-x. Epub 2019 Jul 8. PMID: 31286226
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). Cancer. 2020 Oct 1;126(19):4423-4431. doi: 10.1002/cncr.33100. Epub 2020 Jul 28. PMID: 32786044
Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers. Elad S, Jensen SB, Raber-Durlacher JE, Mouradian N, Correa EM, Schubert MM, Blijlevens NM, Epstein JB, Saunders DP, Waltimo T, Yarom N, Zadik Y, Brennan MT. Support Care Cancer. 2015 Jun;23(6):1615-22. doi: 10.1007/s00520-014-2503-x. Epub 2014 Nov 23. PMID: 25417041
Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Elad S, Raber-Durlacher JE, Brennan MT, Saunders DP, Mank AP, Zadik Y, Quinn B, Epstein JB, Blijlevens NM, Waltimo T, Passweg JR, Correa ME, Dahllöf G, Garming-Legert KU, Logan RM, Potting CM, Shapira MY, Soga Y, Stringer J, Stokman MA, Vokurka S, Wallhult E, Yarom N, Jensen SB. Support Care Cancer. 2015 Jan;23(1):223-36. doi: 10.1007/s00520-014-2378-x. Epub 2014 Sep 5. PMID: 25189149
A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions. Elad S, Ranna V, Ariyawardana A, Correa ME, Tilly V, Nair RG, Rouleau T, Logan RM, Pinto A, Charette V, Saunders DP, Jensen SB; Viral Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). Support Care Cancer. 2017 Feb;25(2):687-700. doi: 10.1007/s00520-016-3477-7. Epub 2016 Nov 16. PMID: 27853930
Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Hong CHL, Gueiros LA, Fulton JS, Cheng KKF, Kandwal A, Galiti D, Fall-Dickson JM, Johansen J, Ameringer S, Kataoka T, Weikel D, Eilers J, Ranna V, Vaddi A, Lalla RV, Bossi P, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). Support Care Cancer. 2019 Oct;27(10):3949-3967. doi: 10.1007/s00520-019-04848-4. Epub 2019 Jul 8. PMID: 31286232
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT; Salivary Gland Hypofunction/Xerostomia Section; Oral Care Study Group; Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). Support Care Cancer. 2010 Aug;18(8):1061-79. doi: 10.1007/s00520-010-0837-6. Epub 2010 Mar 25. PMID: 20333412
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT; Salivary Gland Hypofunction/Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). Support Care Cancer. 2010 Aug;18(8):1039-60. doi: 10.1007/s00520-010-0827-8. Epub 2010 Mar 17. PMID: 20237805
Bacterial extracellular polymeric substances as potential saliva substitute. Kardas P, Astasov-Frauenhoffer M, Braissant O, Bornstein MM, Waltimo T. FEMS Microbiol Lett. 2022 Apr 1;369(1):fnac028. doi: 10.1093/femsle/fnac028. PMID: 35311987
Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines. Logan RM, Al-Azri AR, Bossi P, Stringer AM, Joy JK, Soga Y, Ranna V, Vaddi A, Raber-Durlacher JE, Lalla RV, Cheng KKF, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Support Care Cancer. 2020 May;28(5):2485-2498. doi: 10.1007/s00520-019-05170-9. Epub 2020 Feb 21. PMID: 32080767
Longitudinal assessment of hematopoietic stem cell transplantation and hyposalivation. Laaksonen M, Ramseier AM, Rovó A, Jensen SB, Raber-Durlacher JE, Zitzmann NU, Waltimo T. J Dent Res. 2011 Oct;90(10):1177-82. doi: 10.1177/0022034511414156. Epub 2011 Jul 6. PMID: 21734227
Human leukocyte antigens are associated with salivary level of active MMP-8. Mauramo M, Mauramo E, Sorsa T, Tervahartiala T, Räisänen IT, Waltimo T. Clin Exp Dent Res. 2021 Oct;7(5):833-839. doi: 10.1002/cre2.419. Epub 2021 Aug 27. PMID: 34448550
Determinants of stimulated salivary flow among haematopoietic stem cell transplantation recipients. Mauramo M, Rohde L, Ramseier AM, Rovó A, Waltimo T. Clin Oral Investig. 2017 Jan;21(1):121-126. doi: 10.1007/s00784-016-1760-0. Epub 2016 Feb 25. PMID: 26911494
Associations of HLA-A, -B and -DRB1 types with oral diseases in Swiss adults. Mauramo M, Ramseier AM, Buser A, Tiercy JM, Weiger R, Waltimo T. PLoS One. 2014 Jul 29;9(7):e103527. doi: 10.1371/journal.pone.0103527. eCollection 2014. PMID: 25072155
Associations of oral fluid MMP-8 with periodontitis in Swiss adult subjects. Mauramo M, Ramseier AM, Mauramo E, Buser A, Tervahartiala T, Sorsa T, Waltimo T. Oral Dis. 2018 Apr;24(3):449-455. doi: 10.1111/odi.12769. Epub 2017 Oct 11. PMID: 28889479
Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline. Mercadante V, Jensen SB, Smith DK, Bohlke K, Bauman J, Brennan MT, Coppes RP, Jessen N, Malhotra NK, Murphy B, Rosenthal DI, Vissink A, Wu J, Saunders DP, Peterson DE. J Clin Oncol. 2021 Sep 1;39(25):2825-2843. doi: 10.1200/JCO.21.01208. Epub 2021 Jul 20. PMID: 34283635
MASCC/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients. Miranda-Silva W, Gomes-Silva W, Zadik Y, Yarom N, Al-Azri AR, Hong CHL, Ariyawardana A, Saunders DP, Correa ME, Arany PR, Bowen J, Cheng KKF, Tissing WJE, Bossi P, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer / International Society for Oral Oncology (MASCC/ISOO). Support Care Cancer. 2021 Jul;29(7):3539-3562. doi: 10.1007/s00520-020-05803-4. Epub 2020 Nov 6.PMID: 33156403
The role of benzydamine in prevention and treatment of chemoradiotherapy-induced mucositis. Nicolatou-Galitis O, Bossi P, Orlandi E, René-Jean Bensadoun. Support Care Cancer. 2021 Oct;29(10):5701-5709. doi: 10.1007/s00520-021-06048-5. Epub 2021 Mar 1. PMID: 33649918
Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. Nicolatou-Galitis O, Kouri M, Papadopoulou E, Vardas E, Galiti D, Epstein JB, Elad S, Campisi G, Tsoukalas N, Bektas-Kayhan K, Tan W, Body JJ, Migliorati C, Lalla RV; MASCC Bone Study Group. Support Care Cancer. 2019 Feb;27(2):383-394. doi: 10.1007/s00520-018-4501-x. Epub 2018 Oct 23. PMID: 30353228
Special Section on the MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis – 2019 Update Part 2 : Guest Editor: Sharon Elad, DMD MSc. [No authors listed] Support Care Cancer. 2020 May;28(5):2443. doi: 10.1007/s00520-020-05360-w. PMID: 32198653
Erratum to ”MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy”. [No authors listed] Cancer. 2021 Oct 1;127(19):3700. doi: 10.1002/cncr.33549. Epub 2021 Jul 7. PMID: 34233011
Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods. Ranna V, Cheng KKF, Castillo DA, Porcello L, Vaddi A, Lalla RV, Bossi P, Elad S; Mucositis Study group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). Support Care Cancer. 2019 Oct;27(10):3933-3948. doi: 10.1007/s00520-019-04891-1. Epub 2019 Jul 8. PMID: 31286227
Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor. Rovó A, Daikeler T, Halter J, Heim D, Tsakiris DA, Stern M, Waltimo T, Studt JD, Tyndall A, Gratwohl A, Tichelli A. Haematologica. 2011 Jan;96(1):150-5. doi: 10.3324/haematol.2010.030874. Epub 2010 Sep 17. PMID: 20851864
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD, Rao NG, Potting C, Cheng KK, Freidank A, Brennan MT, Bowen J, Dennis K, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Support Care Cancer. 2013 Nov;21(11):3191-207. doi: 10.1007/s00520-013-1871-y. Epub 2013 Jul 6. PMID: 23832272
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines. Saunders DP, Rouleau T, Cheng K, Yarom N, Kandwal A, Joy J, Bektas Kayhan K, van de Wetering M, Brito-Dellan N, Kataoka T, Chiang K, Ranna V, Vaddi A, Epstein J, Lalla RV, Bossi P, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Support Care Cancer. 2020 May;28(5):2473-2484. doi: 10.1007/s00520-019-05181-6. Epub 2020 Feb 12. PMID: 32052137
Common oral diseases in allogeneic haematopoietic stem cell transplantation (HSCT) recipients pre-HSCT. Uutela P, Passweg J, Halter J, Weiger R, Waltimo T, Mauramo M. Eur J Haematol. 2019 Apr;102(4):351-356. doi: 10.1111/ejh.13209. Epub 2019 Jan 30. PMID: 30632215
Common oral diseases, hyposalivation and survival post-HSCT, a longitudinal study. Uutela P, Passweg J, Halter J, Gerull S, Weiger R, Mauramo E, Waltimo T, Mauramo M. Eur J Haematol. 2019 Oct;103(4):300-306. doi: 10.1111/ejh.13283. Epub 2019 Jul 11. PMID: 31240771
Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action. Wardill HR, Sonis ST, Blijlevens NMA, Van Sebille YZA, Ciorba MA, Loeffen EAH, Cheng KKF, Bossi P, Porcello L, Castillo DA, Elad S, Bowen JM; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Support Care Cancer. 2020 Nov;28(11):5059-5073. doi: 10.1007/s00520-020-05579-7. Epub 2020 Jun 26.PMID: 32592033
Review of oral mucositis treatment guidelines with an emphasis on laser therapy. Walinski CJ, Mellusi SM, Brodeur AE, Marchick E, Katz D, Van Putten M. Gen Dent. 2022 Mar-Apr;70(2):22-26. PMID: 35225799
Correction to: Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and Clinical Practice Guidelines – Part 1: vitamins, minerals and nutritional supplements. Yarom N, Hovan A, Bossi P, Ariyawardana A, Jensen SB, Gobbo M, Saca-Hazboun H, Kandwal A, Majorana A, Ottaviani G, Pentenero M, Nasr NM, Rouleau T, Lucas AS, Treister NS, Zur E, Ranna V, Vaddi A, Cheng KKF, Barasch A, Lalla RV, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology (MASCC/ISOO). Support Care Cancer. 2021 Jul;29(7):4175-4176. doi: 10.1007/s00520-021-06141-9. PMID: 33761004
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline. Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL, Migliorati CA, Khan A, Morrison A, Anderson H, Murphy BA, Alston-Johnson D, Mendes RA, Beadle BM, Jensen SB, Saunders DP. J Clin Oncol. 2019 Sep 1;37(25):2270-2290. doi: 10.1200/JCO.19.01186. Epub 2019 Jul 22. PMID: 31329513
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. Yarom N, Hovan A, Bossi P, Ariyawardana A, Jensen SB, Gobbo M, Saca-Hazboun H, Kandwal A, Majorana A, Ottaviani G, Pentenero M, Nasr NM, Rouleau T, Lucas AS, Treister NS, Zur E, Ranna V, Vaddi A, Cheng KKF, Barasch A, Lalla RV, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology (MASCC/ISOO). Support Care Cancer. 2019 Oct;27(10):3997-4010. doi: 10.1007/s00520-019-04887-x. Epub 2019 Jul 8.PMID: 31286229
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines – part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents. Yarom N, Hovan A, Bossi P, Ariyawardana A, Jensen SB, Gobbo M, Saca-Hazboun H, Kandwal A, Majorana A, Ottaviani G, Pentenero M, Nasr NM, Rouleau T, Lucas AS, Treister NS, Zur E, Ranna V, Vaddi A, Barasch A, Lalla RV, Cheng KKF, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer / International Society of Oral Oncology (MASCC/ISOO). Support Care Cancer. 2020 May;28(5):2457-2472. doi: 10.1007/s00520-019-05256-4. Epub 2020 Feb 13. PMID: 32056010
Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Zadik Y, Arany PR, Fregnani ER, Bossi P, Antunes HS, Bensadoun RJ, Gueiros LA, Majorana A, Nair RG, Ranna V, Tissing WJE, Vaddi A, Lubart R, Migliorati CA, Lalla RV, Cheng KKF, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).Support Care Cancer. 2019 Oct;27(10):3969-3983. doi: 10.1007/s00520-019-04890-2. Epub 2019 Jul 8. PMID: 31286228
Strategic considerations in treatment planning: deciding when to treat, extract, or replace a questionable tooth. Zitzmann NU, Krastl G, Hecker H, Walter C, Waltimo T, Weiger R. J Prosthet Dent. 2010 Aug;104(2):80-91. doi: 10.1016/S0022-3913(10)60096-0. PMID: 20654764